Skip to content
healthcare.dev

Topiramate

NDC 69680-179, Topiramate, capsule, extended release, from Vitruvias Therapeutics, Inc..

Product NDC
69680-179
Status
Listed
Labeler
Vitruvias Therapeutics, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215638
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69680-179 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
69680-179-306968001793030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-179-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a9d7c5ef-daf9-4f97-8673-7f4a2007f408
  • NADAC price for package 69680017930

    GET /v1/drugs/nadac/69680017930

Use it

Look up 69680-179 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69680-179 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69680-179. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.